Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Bia Energy is transforming LatAm’s power sector with smart meters and a digital platform for real-time control, savings, and sustainability.
Cortica provides neurological therapies for children with autism and other developmental differences.
We provide neurodegenerative disease patients with expert MDs and 24/7 wrap around care, no matter where you live in the US
Metsera is a clinical‐stage biotech firm developing oral & injectable hormone therapies to treat obesity & related metabolic diseases.
ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.
Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients.
Innoventric, a start-up company from Ness-Ziona, Israel, develops the unique Trillium technology
Alpha-9 Oncology is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.
Ervaxx is illuminating the immune interface to develop new cancer therapies.
Aktis Oncology is a biotechnology company that designs and develops novel class radiopharmaceuticals.
Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.
Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal.
Elektrofi is a preclinical-stage company dedicated to redefining the standard of drug delivery by transforming the patient experience.
Halda Therapeutics is a research-stage drug discovery company.
Idrx is a clinical-stage biopharmaceutical that develops oncology-based precision therapies to treat cancer.
MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.
Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.
Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.
Vesta Healthcare is a technology and clinical services organization that offers virtual care services.
LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.
AM Batteries manufactures Li-ion batteries using solvent-free electrode manufacturing technology.
Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.
RA Capital Management has invested in 467 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
RA Capital Management's top investment sectors include Health Care, Biotechnology, Therapeutics, Pharmaceutical, Medical. The firm invests across 31 different industry categories.
Among tracked funding rounds, Metsera received $215.0M in a Series B round. RA Capital Management's total known invested capital is $56.7B.
RA Capital Management's average investment size is $123.5M across its portfolio of 467 companies.
Recent RA Capital Management portfolio additions include Bia Energy, Cortica, Synapticure, Metsera, Alentis Therapeutics. These companies were founded in 2020 or later.